Equities

Praram 9 Hospital PCL

Praram 9 Hospital PCL

Actions
Health CareHealth Care Providers
  • Price (THB)19.20
  • Today's Change0.10 / 0.52%
  • Shares traded3.47m
  • 1 Year change+7.26%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Praram 9 Hospital Public Company Limited is a Thailand-based company engaged in the hospital business. The Company is primarily engaged in operating a general hospital under the name Praram 9 Hospital. It provides comprehensive healthcare services, including both general and specialized medical services. It has over three medical institutes, including Praram 9 kidney disease & Transplantation Institute, Praram 9 Cardiovascular Institute and Advanced Pain Management & Wellness Institute (Fix & FIT). It also has over 28 medical centers, including medicine center, surgery center, diabetes & metabolic center, neurology center, emergency center, pediatric center, advanced spine center, orthopedic center, and others. Its total number of registered beds is over 204 beds. It provides tertiary care services, including health promotion service, prevention, treatment and rehabilitation of general diseases, such as obstetrics gynecology, surgery, general medicine, pediatrics, and orthopedics.

  • Revenue in THB (TTM)4.33bn
  • Net income in THB608.03m
  • Incorporated1977
  • Employees2.21k
  • Location
    Praram 9 Hospital PCL99 Rama IX Road, Bang Kapi, HuaykwangBangkok 10310ThailandTHA
  • Phone+66 22029999
  • Fax+66 22029998
  • Websitehttps://www.praram9.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Rajthanee Hospital PCL2.42bn428.94m7.58bn1.11k17.703.5913.243.131.431.438.047.040.636833.794.752,173,544.0011.1623.9614.5432.8231.3338.7917.5226.301.0524.360.320677.94-30.248.14-59.2210.5236.4411.38
Chiang Mai Ram Medical Business PCL5.17bn241.91m7.98bn1.59k32.911.988.931.540.05960.05961.280.99140.399133.437.463,241,176.003.043.415.715.9923.4623.637.629.050.31099.700.357487.27-2.675.18-56.78-10.322.731.13
Wattanapat Hospital Trang PCL1.71bn183.44m8.55bn538.0043.945.6826.985.000.2890.2892.752.230.672525.448.94--7.304.708.345.5328.8425.8210.857.791.315.540.397759.1227.4218.45-19.6712.541.879.86
Klinique Medical Clinic PCL2.46bn294.83m9.35bn1.05k31.715.2618.413.791.341.3411.208.080.85086.4446.002,342,106.0010.1813.5214.0523.0952.8856.5811.9712.901.48--0.23--39.4123.1040.4576.6937.97--
Principal Capital PCL5.96bn-587.56m15.01bn3.80k--1.71104.332.52-0.1543-0.15431.562.300.327735.168.661,569,561.00-3.36-1.26-4.46-1.5721.5324.05-10.27-4.470.3678-1.230.442---15.6316.23-387.63--6.30--
Praram 9 Hospital PCL4.33bn608.03m15.10bn2.21k24.832.8816.623.490.77330.77335.516.660.744361.7421.111,961,083.0010.457.3311.588.2633.5331.1214.0411.073.98--0.001641.402.279.31-1.7228.83-17.7615.68
Master Style PCL1.95bn450.98m18.86bn756.0046.645.3335.489.681.341.345.8711.730.554510.04207.432,578,086.0012.8326.1614.0734.1159.1255.3223.1421.094.4940.180.087--29.2855.4738.34147.61----
Sikarin PCL6.01bn915.80m21.47bn1.75k23.372.8215.253.570.4450.4452.923.690.6624.665.032,031,677.0010.1210.7411.5012.9034.0435.4915.3315.472.2232.390.073731.512.6011.08-11.9229.7421.5119.42
Data as of May 31 2024. Currency figures normalised to Praram 9 Hospital PCL's reporting currency: Thai Baht THB

Institutional shareholders

16.58%Per cent of shares held by top holders
HolderShares% Held
Krungsri Asset Management Co., Ltd.as of 28 Dec 202358.94m7.50%
UOB Asset Management (Thailand) Co., Ltd.as of 28 Dec 202315.79m2.01%
Aberdeen Asset Management (Thailand) Co., Ltd.as of 28 Dec 202310.31m1.31%
Thanachart Fund Management Co., Ltd.as of 28 Dec 202310.08m1.28%
SCB Asset Management Co., Ltd.as of 28 Dec 20239.78m1.24%
abrdn Australia Ltd.as of 28 Dec 20237.11m0.90%
Norges Bank Investment Managementas of 31 Dec 20237.06m0.90%
Bangkok Life Assurance Public Co., Ltd. (Investment Portfolio)as of 14 Mar 20236.07m0.77%
BBL Asset Management Co., Ltd.as of 28 Dec 20232.65m0.34%
Eastspring Asset Management (Thailand) Co., Ltd.as of 28 Dec 20232.56m0.33%
More ▼
Data from 28 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.